Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRESS LIMITED Capital/Financing Update 2020

Jun 4, 2020

65141_rns_2020-06-04_3c124225-c36f-475b-868c-84fafd72b847.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [94 x 74] intentionally omitted <==

IRESS LIMITED

NOTICE UNDER SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001 (CTH)

5 JUNE 2020

This notice is given by Iress Limited (ASX: IRE) (“Iress”) under section 708A(5)(e) of the ​ Corporations Act 2001​ (Cth) (the “Act”).

Iress confirms that:

  • a. it has completed the issue and allotment of 14,395,394 fully paid ordinary shares in Iress (“New Shares”) at a price of $10.42 per New Share pursuant to a placement, the results of which were announced to the ASX on 2 June 2020;

  • b. the New Shares were issued without disclosure under Part 6D.2 of the Act;

  • c. as at the date of this notice, Iress has complied with:

    • i. the provisions of Chapter 2M of the Act as they apply to Iress; and

    • ii. section 674 of the Act; and

  • d. as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Act that is required to be set out in this notice under section 708A(6)(e) of the Act.

Authorised by:

==> picture [114 x 49] intentionally omitted <==

Peter Ferguson

Group General Counsel & Company Secretary

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

This announcement does not constitute an offer to sell, or the solicitation of an offer to buy, any securities in the United States or any other jurisdiction in which such an offer would be illegal. The securities referred to in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state or other jurisdiction of the United States. Accordingly, the New Shares may not be offered or sold, directly or indirectly, in the United States unless they have been registered under the U.S. Securities Act (which Iress is under no obligation to do) or are offered or sold pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable securities laws of any state or other jurisdiction of the United States.

ENDS